- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/084 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
Patent holdings for IPC class C07D 295/084
Total number of patents in this class: 39
10-year publication summary
|
5
|
3
|
3
|
2
|
1
|
4
|
3
|
2
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| British Columbia Cancer Agency Branch | 182 |
4 |
| The University of British Columbia | 1538 |
4 |
| Massachusetts Institute of Technology | 10251 |
3 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 226 |
3 |
| 3m Innovative Properties Company | 17478 |
2 |
| Dow Global Technologies LLC | 10944 |
2 |
| FMC Corporation | 807 |
2 |
| Neuropro Therapeutics, Inc. | 22 |
2 |
| Receptos LLC | 61 |
2 |
| Sirna Therapeutics, Inc. | 99 |
2 |
| BASF SE | 21303 |
1 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11123 |
1 |
| JSR Corporation | 2554 |
1 |
| Celgene International II Sàrl | 28 |
1 |
| Consejo Superior de Investigaciones Cientificas | 798 |
1 |
| Novira Therapeutics, Inc. | 32 |
1 |
| Shanghai East Hospital | 8 |
1 |
| Shanghai Institute of Pharmaceutical Industry | 127 |
1 |
| Universita degli Studi di BARI "aldo Moro" | 51 |
1 |
| Universite Laval | 708 |
1 |
| Other owners | 3 |